Search Results

There are 5361 results for: content related to: Medication Information for Patients with Limited English Proficiency: Lessons from the European Union

  1. Regulatory Aspects of Pharmacovigilance

    Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice, Sixth Edition

    Kristina Leila Strutt, Barry David Charles Arnold, Pages: 411–509, 2012

    Published Online : 30 JAN 2012, DOI: 10.1002/9780470975053.ch8

  2. New pathway for qualification of novel methodologies in the European medicines agency

    PROTEOMICS - Clinical Applications

    Volume 5, Issue 5-6, June 2011, Pages: 248–255, Efthymios Manolis, Spiros Vamvakas and Maria Isaac

    Article first published online : 28 APR 2011, DOI: 10.1002/prca.201000130

  3. Methods to Derive Withdrawal Periods in the European Union

    Strategies for Reducing Drug and Chemical Residues in Food Animals: International Approaches to Residue Avoidance, Management, and Testing

    G. Johan Schefferlie, Stefan Scheid, Pages: 65–79, 2014

    Published Online : 11 AUG 2014, DOI: 10.1002/9781118872819.ch5

  4. Establishing Maximum Residue Limits in Europe

    Strategies for Reducing Drug and Chemical Residues in Food Animals: International Approaches to Residue Avoidance, Management, and Testing

    Kornelia Grein, Isaura Duarte, Pages: 49–63, 2014

    Published Online : 11 AUG 2014, DOI: 10.1002/9781118872819.ch4

  5. Role of modeling and simulation in pediatric investigation plans

    Pediatric Anesthesia

    Volume 21, Issue 3, March 2011, Pages: 214–221, Efthymios Manolis, Tariq Eldirdiry Osman, Ralf Herold, Franz Koenig, Paolo Tomasi, Spiros Vamvakas and Agnes Saint Raymond

    Article first published online : 18 JAN 2011, DOI: 10.1111/j.1460-9592.2011.03523.x

  6. You have free access to this content
    Appendix 5: The New EU Risk Management Plan

    Pharmacovigilance Medical Writing: A Good Practice Guide

    Justina Orleans-Lindsay, Pages: 215–225, 2012

    Published Online : 19 JUN 2012, DOI: 10.1002/9781118301906.app5

  7. Quality Control and Good Manufacturing Practice (GMP) for Chitosan-Based Biopharmaceutical Products

    Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics

    Torsten Richter, Maika Gulich, Katja Richter, Pages: 503–524, 2012

    Published Online : 17 FEB 2012, DOI: 10.1002/9781119962977.ch26

  8. Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium

    Drug Development Research

    Volume 74, Issue 2, March 2013, Pages: 112–126, Eslie H. Dennis, Elizabeth G. Walker, Amanda F. Baker and Richard T. Miller

    Article first published online : 22 FEB 2013, DOI: 10.1002/ddr.21070

  9. Proactive Pharmacovigilance and Risk Management

    Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice, Sixth Edition

    June Raine, Lesley Wise, John Talbot, Jeffrey K. Aronson, Pages: 389–409, 2012

    Published Online : 30 JAN 2012, DOI: 10.1002/9780470975053.ch7

  10. A statistician's perspective on biomarkers in drug development

    Pharmaceutical Statistics

    Volume 10, Issue 6, November/December 2011, Pages: 494–507, Martin Jenkins, Aiden Flynn, Trevor Smart, Chris Harbron, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis, James Matcham and on behalf of the PSI Biomarker Special Interest Group

    Article first published online : 8 DEC 2011, DOI: 10.1002/pst.532

  11. Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 8, October 2013, Pages: 914–924, M. Rinaudo-Gaujous, S. Paul, E. D. Tedesco, C. Genin, X. Roblin and L. Peyrin-Biroulet

    Article first published online : 3 SEP 2013, DOI: 10.1111/apt.12477

  12. Clinical Trials—Collecting Safety Data and Establishing the Adverse Drug Reactions Profile

    Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice, Sixth Edition

    John Talbot, Marianne Keisu, Lars Ståhle, Pages: 215–289, 2012

    Published Online : 30 JAN 2012, DOI: 10.1002/9780470975053.ch4

  13. You have full text access to this OnlineOpen article
    Non-clinical safety evaluation of single and repeated intramuscular administrations of MAGE-A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys

    Journal of Applied Toxicology

    Eric Destexhe, Emilie Grosdidier, Nathalie Baudson, Roy Forster, Catherine Gerard, Nathalie Garçon and Lawrence Segal

    Article first published online : 12 SEP 2014, DOI: 10.1002/jat.3025

  14. You have free access to this content
    Future of the European Union regulatory network in the context of the uptake of new medicines

    British Journal of Clinical Pharmacology

    Volume 76, Issue 1, July 2013, Pages: 1–6, Joëlle M. Hoebert, Alar Irs, Aukje K. Mantel-Teeuwisse and Hubert G. M. Leufkens

    Article first published online : 20 JUN 2013, DOI: 10.1111/j.1365-2125.2012.04476.x

  15. Compassionate medicine-use programmes in Turkey: a report on current status

    Journal of Pharmaceutical Health Services Research

    Volume 3, Issue 3, September 2012, Pages: 129–134, Elif H. Vural, Guvenc Kockaya, Pelin Tanyeri, Salih Babacan, İ. Mert Vural, Akif Akbulat, Güven Artıran, Halil Akar, Mahmut Tokaç and Saim Kerman

    Article first published online : 25 MAY 2012, DOI: 10.1111/j.1759-8893.2012.00090.x

  16. You have free access to this content
    Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?

    Tropical Medicine & International Health

    Volume 19, Issue 1, January 2014, Pages: 23–36, Joachim Y. Doua and Jean-Pierre Van Geertruyden

    Article first published online : 17 OCT 2013, DOI: 10.1111/tmi.12201

  17. You have free access to this content
    Appendix 4: The New Pharmacovigilance Legislation in the EU

    Pharmacovigilance Medical Writing: A Good Practice Guide

    Justina Orleans-Lindsay, Pages: 211–214, 2012

    Published Online : 19 JUN 2012, DOI: 10.1002/9781118301906.app4

  18. Digital switchover in UHF: the ATHENA concept for broadband access

    European Transactions on Telecommunications

    Volume 17, Issue 2, March/April 2006, Pages: 175–182, Evangelos Pallis, Charalambos Mantakas, George Mastorakis, Anastasios Kourtis and Vassilios Zacharopoulos

    Article first published online : 29 MAR 2006, DOI: 10.1002/ett.1099

  19. You have free access to this content
    Bibliography

    Cost-Contained Regulatory Compliance: For the Pharmaceutical, Biologics, and Medical Device Industries

    Sandy Weinberg, Pages: 273–277, 2011

    Published Online : 8 MAR 2011, DOI: 10.1002/9780470933510.biblio

  20. You have free access to this content
    Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children

    Allergy

    Volume 66, Issue 8, August 2011, Pages: 999–1004, I. Eichler and E. Sala Soriano

    Article first published online : 23 MAR 2011, DOI: 10.1111/j.1398-9995.2011.02582.x